Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03815253
Other study ID # HKBU-HMRF
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2019
Est. completion date February 28, 2021

Study information

Verified date March 2021
Source Hong Kong Baptist University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, a 8-week, single blinded, randomized controlled clinical trial will be conducted to examine the efficacy and safety of body acupuncture in the treatment of central obesity in Hong Kong.


Description:

This is a pilot single-blind, randomized, sham-controlled trial. 168 central obesity patients will be randomly assigned to acupuncture group or control group. The duration of the treatment will be 8 weeks with 2 session per week and the follow-up period will be 2 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 168
Est. completion date February 28, 2021
Est. primary completion date January 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: Patients who meet all of the following criteria are defined as eligible participants: men and women aged between 18 and 65 years old; BMI = 25 kg/m2; central obesity, defined as WC of = 90 cm in men and = 80 cm in non-pregnant women according to ICD-10 [24]; not receiving any other weight control measures or any medical and/or drug history in last 3months. Exclusion Criteria: Patients who meet any of the following criteria should be excluded from the study: endocrine diseases, including thyroid disorder, pituitary disorder, sex gland disorder, etc.; heart diseases, including arrhythmia, heart failure, myocardial infarction, patients with pacemaker; allergy and immunology diseases; bleeding tendency; pregnant or lactating women; impaired hepatic or renal function; stroke or unable to exercise.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
acupuncture
Body electro-acupuncture will choose eight acupoints as Tianshu(ST-25), Daheng(SP-15), Daimai(GB-26), Qihai(CV-6), Zhongwan(CV-12), Zusanli (ST-36), Fenlong(ST-40), Sanyinjiao(SP-6).Disposable acupuncture needles (verum acupuncture needles asia-med Special No. 16 with 0.30 x 0.30mm matching the Streitberger sham-needles) will be inserted at a depth of 10-25 mm into the points. We will also deliver electrical stimulation with dense-disperse waves with 50Hz at 10 volts through electrical acupuncture stimulation instrument (ES-160 6-Channel Programmable Electro-acupuncture) to the abdominal points. The bodily needles will be retained for 30 minutes.

Locations

Country Name City State
Hong Kong Linda Zhong Kowloon Tong Kowloon

Sponsors (2)

Lead Sponsor Collaborator
Hong Kong Baptist University Princess Margaret Hospital, Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in waist circumference Waist circumference will be measured around the abdomen at the level of the umbilicus (belly button). 0,1,2,3,4,5,6,7,8, 11, 15,18, 21, 24 weeks
Secondary Changes in hip circumference hip circumference measured at the level of maximum posterior extension of the buttocks 0,1,2,3,4,5,6,7,8,9,11,15,18, 21, 24 weeks
Secondary Adverse events after treatment and follow up Adverse events of acupuncture treatment will be assessed using the Treatment Emergent Symptom Scale (TESS) and would be evaluated during the whole procedure, as well as laboratory tests (whole blood counts, renal and liver functions) if needed. All clinical adverse events will be recorded in terms of intensity (mild, moderate, or severe), duration, outcome and relationship to the study. 0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks
Secondary Changes in waist-to-hip circumference ratio waist-to-hip ratio is the dimensionless ratio of the circumference of the waist to that of the hips. This is calculated as waist measurement divided by hip measurement ( W รท H ). 0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks
Secondary Changes in Body Mass Index Body Mass Index is a simple calculation using a person's height and weight. The formula is BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in metres squared. 0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks
Secondary Changes in body fat percentage The body fat percentage (BFP) of a human or other living being is the total mass of fat divided by total body mass, multiplied by 100. Body fat percentage will be measured by Omron Karada Scan HBF-701. 0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks
Secondary Changes in total cholesterol (TC), triglyceride (TG) and fasting blood glucose (FBG) Total cholesterol (TC), triglyceride (TG) and fasting blood glucose (FBG) will be measured before and after the 8-week treatment. 0, 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT02375113 - Soy as an Innovative Dietary Component in Abdominal Obesity Management Amongst Peri- and Early Menopausal Women N/A
Withdrawn NCT04545320 - Effectiveness of High-intensity Interval Training (HIIT) Versus Moderate-intensity Continuous Training (MICT) in Reducing Visceral Fat in Adults With Central Obesity N/A
Completed NCT04807959 - Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program
Completed NCT03665961 - The Association Between Microbiota, Endotoxaemia and the Host Obesity/ Insulin Resistance (MiPOOP Study)
Recruiting NCT05833009 - Acupuncture Treatment for Schizophrenia-related Central Obesity N/A
Completed NCT01881373 - Children's Healthy Living Community Randomized Trial N/A
Recruiting NCT05121844 - Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform N/A
Recruiting NCT05874635 - Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) N/A
Withdrawn NCT03120390 - Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors N/A
Completed NCT04152213 - The Effects of Low Glycemic Index (GI) Diet on Cardiometabolic Outcomes Among Obese Chinese Adults N/A
Completed NCT04761081 - Is Physical Activity, Obesity, and Ethnicity Associated With the Tethering and Migration of Pro-inflammatory Monocytes?
Completed NCT02987595 - Effects of Lignan-rich Diet on Cardiometabolic Risk Factors N/A
Not yet recruiting NCT03552237 - Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients N/A
Recruiting NCT06024018 - Effect of High Intensity Electromagnetic Body Shaping on Profile of Metabolism in Obese Men N/A
Withdrawn NCT03091842 - Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer N/A
Completed NCT02320760 - Physical Activity on Prescription in Overweight Older Adults N/A
Active, not recruiting NCT03912272 - 12-Month Once-a-week HIIT Improves Body Adiposity and Liver Fat N/A
Completed NCT02010060 - Aerobic Training and Non-Exercise Physical Activity N/A
Completed NCT01445730 - Fructose Consumption and Metabolic Dysregulation N/A
Completed NCT03279432 - Vitamin D-related Genes and Metabolic Disorders N/A